Key result
Targeting SUMOylation emerges as a potential therapeutic strategy across cardiovascular development and disease.
Answers are grounded in this paper and cite their sources.
Review highlights the impact of SUMOylation on cardiovascular functions, suggesting therapeutic potential for cardiovascular diseases.
Cardiovascular disease (CVD) is a common disease caused by many factors, including atherosclerosis, congenital heart disease, heart failure, and ischemic cardiomyopathy. CVD has been regarded as one of the most common diseases and has a severe impact on the life quality of patients. The main features of CVD include high morbidity and mortality, which seriously threaten human health. SUMO proteins covalently conjugate lysine residues with a large number of substrate proteins, and SUMOylation regulates the function of target proteins and participates in cellular activities. Under certain pathological conditions, SUMOylation of proteins related to cardiovascular development and function are greatly changed. Numerous studies have suggested that SUMOylation of substrates plays critical roles in normal cardiovascular development and function. We reviewed the research progress of SUMOylation in cardiovascular development and function, and the regulation of protein SUMOylation may be applied as a potential therapeutic strategy for CVD treatment.
No takes yet. Share an insight, caveat, or question.
Du et al. (2021) conducted a review in Cardiovascular disease. SUMOylation was evaluated. SUMOylation plays critical roles in cardiovascular development and function, and its regulation may serve as a potential therapeutic strategy for cardiovascular disease treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: